Terada H
Faculty of Pharmaceutical Sciences, University of Tokushima, Japan.
Environ Health Perspect. 1990 Jul;87:213-8. doi: 10.1289/ehp.9087213.
Uncouplers of oxidative phosphorylation in mitochondria inhibit the coupling between the electron transport and phosphorylation reactions and thus inhibit ATP synthesis without affecting the respiratory chain and ATP synthase (H(+)-ATPase). Miscellaneous compounds are known to be uncouplers, but weakly acidic uncouplers are representative because they show very potent activities. The most potent uncouplers discovered so far are the hindered phenol SF 6847, and hydrophobic salicylanilide S-13, which are active in vitro at concentrations in the 10 nM range. For induction of uncoupling, an acid dissociable group, bulky hydrophobic moiety and strong electron-withdrawing group are required. Weakly acidic uncouplers are considered to produce uncoupling by their protonophoric action in the H(+)-impermeable mitochondrial membrane. For exerting these effects, the stability of the respective uncoupler anions in the hydrophobic membrane is very important. High stability is achieved by delocalization of the polar ionic charge through uncoupler (chemical)-specific mechanisms. Such an action of weakly acidic uncouplers is characteristic of the highly efficient membrane targeting action of a nonsite-specific type of bioactive compound.
线粒体氧化磷酸化的解偶联剂可抑制电子传递与磷酸化反应之间的偶联,从而抑制ATP合成,而不影响呼吸链和ATP合酶(H(+)-ATP酶)。已知多种化合物为解偶联剂,但弱酸性解偶联剂具有代表性,因为它们表现出非常强的活性。迄今为止发现的最有效的解偶联剂是受阻酚SF 6847和疏水水杨酰苯胺S-13,它们在体外10 nM浓度范围内具有活性。诱导解偶联需要一个可酸解离的基团、庞大的疏水部分和强吸电子基团。弱酸性解偶联剂被认为是通过其在H(+)-不可渗透的线粒体膜中的质子载体作用产生解偶联的。为了发挥这些作用,各个解偶联剂阴离子在疏水膜中的稳定性非常重要。通过解偶联剂(化学)特异性机制使极性离子电荷离域可实现高稳定性。弱酸性解偶联剂的这种作用是非位点特异性生物活性化合物高效膜靶向作用的特征。